Article
Integrating Transcriptomics, Genomics, and Imaging in Alzheimer’s Disease: A Federated Model
2021-09-16
Abstract excerpt
Alzheimer’s disease (AD) affects more than 1 in 9 people age 65 and older and becomes an urgent public health concern as the global population ages. In clinical practice, structural magnetic resonance imaging (sMRI) is the most accessible and widely used diagnostic imaging modality. Additionally, genome-wide association studies (GWAS) and transcriptomics – the study of gene expression – also play an important role...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 839f6270-d644-5250-829b-492be6b8056c
- DOI
- 10.1101/2021.09.14.460367
